A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus-Like Particle Vaccine
Condition: Chikungunya Virus Intervention: Biological: CHIKV VLP, adjuvanted Sponsor: Emergent BioSolutions Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials